Related references
Note: Only part of the references are listed.Obesity alters the long-term fitness of the hematopoietic stem cell compartment through modulation of Gfi1 expression
Jung-Mi Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Familial Mediterranean Fever and Incidence of Cancer: An Analysis of 8,534 Israeli Patients With 258,803 Person-Years
Ronen Brenner et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
Shuichiro Takahashi et al.
BLOOD (2018)
Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota
Kamilla S. Josefsdottir et al.
BLOOD (2017)
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
John O. Mascarenhas et al.
HAEMATOLOGICA (2017)
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
John O. Mascarenhas et al.
HAEMATOLOGICA (2017)
The microbiome and systemic lupus erythematosus
Nurit Katz-Agranov et al.
IMMUNOLOGIC RESEARCH (2017)
Impact of inflammation on early hematopoiesis and the microenvironment
Hitoshi Takizawa et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Inflammation and myeloproliferative neoplasms
Federico Lussana et al.
JOURNAL OF AUTOIMMUNITY (2017)
Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders
Daniel C. McFarland et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms
Jie Zhang et al.
JOURNAL OF THEORETICAL BIOLOGY (2017)
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study
Nancy K. Gillis et al.
LANCET ONCOLOGY (2017)
Cytokines in Autoimmune Disease
Qingdong Guan et al.
MEDIATORS OF INFLAMMATION (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Microbiome, inflammation and colorectal cancer
Ju Chen et al.
SEMINARS IN IMMUNOLOGY (2017)
Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib
Mads Emil Bjorn et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Role of Gut Microbiota in Rheumatoid Arthritis
Yuichi Maeda et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development
Morten Andersen et al.
PLOS ONE (2017)
Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis
Shufen Li et al.
SCIENTIFIC REPORTS (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive Fitness
Hitoshi Takizawa et al.
CELL STEM CELL (2017)
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
Shubhasree Banerjee et al.
DRUGS (2017)
The microbiota in inflammatory bowel disease: current and therapeutic insights
Erin R. Lane et al.
JOURNAL OF INFLAMMATION RESEARCH (2017)
Smoking and philadelphia-negative chronic myeloproliferative neoplasms
Anders Lindholm Sorensen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera
Cecilie Utke Rank et al.
LEUKEMIA & LYMPHOMA (2016)
Targeting JAK kinase in solid tumors: emerging opportunities and challenges
M. Buchert et al.
ONCOGENE (2016)
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
David A. Hinds et al.
BLOOD (2016)
Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy
Julia L. Drewes et al.
BRITISH JOURNAL OF CANCER (2016)
Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?
Q. Chen et al.
CELL DEATH AND DIFFERENTIATION (2016)
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy
E. Nievergall et al.
LEUKEMIA (2016)
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S. Koschmieder et al.
LEUKEMIA (2016)
Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?
Mette Vestergaard Elbaek et al.
LEUKEMIA & LYMPHOMA (2016)
Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms
Anders Lindholm Sorensen et al.
LEUKEMIA RESEARCH (2016)
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
Olga A. Guryanova et al.
NATURE MEDICINE (2016)
Chronic Infection Depletes Hematopoietic Stem Cells through Stress-Induced Terminal Differentiation
Katie A. Matatall et al.
CELL REPORTS (2016)
Sepsis Induces Hematopoietic Stem Cell Exhaustion and Myelosuppression through Distinct Contributions of TRIF and MYD88
Huajia Zhang et al.
STEM CELL REPORTS (2016)
Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment
Larisa V. Kovtonyuk et al.
FRONTIERS IN IMMUNOLOGY (2016)
Human and Murine Hematopoietic Stem Cell Aging Is Associated with Functional Impairments and Intrinsic Megakaryocytic/Erythroid Bias
Alexandra Rundberg Nilsson et al.
PLOS ONE (2016)
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Julian Mackay-Wiggan et al.
JCI INSIGHT (2016)
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera
Heinz Gisslinger et al.
BLOOD (2015)
Smoking as a contributing factor for development of polycythemia vera and related neoplasms
Hans Carl Hasselbalch
LEUKEMIA RESEARCH (2015)
Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis
Christophe Desterke et al.
MEDIATORS OF INFLAMMATION (2015)
Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
Holly L. Geyer et al.
MEDIATORS OF INFLAMMATION (2015)
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
Gregor Hoermann et al.
MEDIATORS OF INFLAMMATION (2015)
MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
Hans Carl Hasselbalch et al.
MEDIATORS OF INFLAMMATION (2015)
Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical response
Marco Pizzi et al.
MODERN PATHOLOGY (2015)
JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
Maria Kleppe et al.
CANCER DISCOVERY (2015)
Leukemic transformation in myeloproliferative neoplasms: Therapy-related or unrelated?
Magnus Bjorkholm et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2014)
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
Silvia Spoerl et al.
BLOOD (2014)
Bone marrow fat accumulation accelerated by high fat diet is suppressed by exercise
Maya Styner et al.
BONE (2014)
Gut Microbiota Promote Hematopoiesis to Control Bacterial Infection
Arya Khosravi et al.
CELL HOST & MICROBE (2014)
Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications
Emmanuel Pourcelot et al.
EXPERIMENTAL HEMATOLOGY (2014)
Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature
Maria E. Vergara-Lluri et al.
HUMAN PATHOLOGY (2014)
Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in The Iowa Women's Health Study cohort
Alexis D. Leal et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Interferon Alfa Therapy in CALR-Mutated Essential Thrombocythemia
Bruno Cassinat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Autoimmune diseases and cancers. First part: Cancers complicating autoimmune diseases and their treatment
F. Pasquet et al.
REVUE DE MEDECINE INTERNE (2014)
JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
Leeyen Hsu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera
Ann Mullally et al.
BLOOD (2013)
Proliferation-Dependent Alterations of the DNA Methylation Landscape Underlie Hematopoietic Stem Cell Aging
Isabel Beerman et al.
CELL STEM CELL (2013)
An Update on Autoinflammatory Diseases
F. Ciccarelli et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Cytokine profiles in acute myeloid leukemia patients at diagnosis: Survival is inversely correlated with IL-6 and directly correlated with IL-10 levels
Beatriz Sanchez-Correa et al.
CYTOKINE (2013)
Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia
Filgen Y. Fung et al.
LEUKEMIA RESEARCH (2013)
Differential regulation of myeloid leukemias by the bone marrow microenvironment
Daniela S. Krause et al.
NATURE MEDICINE (2013)
JAK/STAT signaling in hematological malignancies
W. Vainchenker et al.
ONCOGENE (2013)
Chronic TLR Signaling Impairs the Long-Term Repopulating Potential of Hematopoietic Stem Cells of Wild Type but Not Id1 Deficient Mice
Ying Zhao et al.
PLOS ONE (2013)
Lifestyle Factors and Inflammation: Associations by Body Mass Index
Elizabeth D. Kantor et al.
PLOS ONE (2013)
Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
Richard T. Silver et al.
EXPERT REVIEW OF HEMATOLOGY (2013)
Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis
Rakhee Vaidya et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes
A. Krings et al.
BONE (2012)
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
Robyn M. Emanuel et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Dnmt3a is essential for hematopoietic stem cell differentiation
Grant A. Challen et al.
NATURE GENETICS (2012)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The role of gut microbiota in immune homeostasis and autoimmunity
Hsin-Jung Wu et al.
GUT MICROBES (2012)
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
Angela G. Fleischman et al.
BLOOD (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes
Xingmin Feng et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?
Sylvie Hermouet et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
Ayalew Tefferi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
Sigurdur Y. Kristinsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Chronic Exposure to a TLR Ligand Injures Hematopoietic Stem Cells
Brandt L. Esplin et al.
JOURNAL OF IMMUNOLOGY (2011)
The Symptom Burden of Patients with Hematological Malignancy: A Cross-Sectional Observational Study
Vanessa Manitta et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2011)
Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F
M. Boissinot et al.
ONCOGENE (2011)
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
Wendy W. Pang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Autoimmunity and the risk of myeloproliferative neoplasms
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Marc H. G. P. Raaijmakers et al.
NATURE (2010)
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Risks of myeloid malignancies in patients with autoimmune conditions
L. A. Anderson et al.
BRITISH JOURNAL OF CANCER (2009)
Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
Alfonso Quintas-Cardama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis
Ruben A. Mesa et al.
LEUKEMIA RESEARCH (2009)
A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
Outi Kilpivaara et al.
NATURE GENETICS (2009)
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
Amy V. Jones et al.
NATURE GENETICS (2009)
Genome-wide association study identifies eight loci associated with blood pressure
Christopher Newton-Cheh et al.
NATURE GENETICS (2009)
The gut microbiota shapes intestinal immune responses during health and disease
June L. Round et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
Jean-Jacques Kiladjian et al.
BLOOD (2008)
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes:: a pooled analysis within the InterLymph consortium
Karin Ekstrom Smedby et al.
BLOOD (2008)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
Proinflammatory cytokines and sickness behavior: Implications for depression and cancer-related symptoms
Jamie S. Myers
ONCOLOGY NURSING FORUM (2008)
Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation
Stuart M. Chambers et al.
PLOS BIOLOGY (2007)
Maternal alcohol and coffee drinking, parental smoking and childhood leukaemia:: a French population-based case-control study
Florence Menegaux et al.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2007)
The speed of evolution and maintenance of variation in asexual populations
Michael M. Desai et al.
CURRENT BIOLOGY (2007)
Acute myeloid leukemia:: Epidemiology and etiology
Barbara Deschler et al.
CANCER (2006)
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome
CA Meyers et al.
CANCER (2005)
Identification of an acquired JAK2 mutation in Polycythemia vera
RX Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Helicobacter pylori and MALT lymphoma
P Farinha et al.
GASTROENTEROLOGY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study
G Finazzi et al.
BLOOD (2005)
Age-related changes in lymphocyte development and function
PJ Linton et al.
NATURE IMMUNOLOGY (2004)
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group
G Lenz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study
DP Steensma et al.
BLOOD (2002)
Age-associated characteristics of murine hematopoietic stem cells
K Sudo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Smoking and myelodysplastic syndromes
J Björk et al.
EPIDEMIOLOGY (2000)
Share Paper
